{"disease":{"id":"adenoma","name":"adenoma"},"drugs":{"marketed":[{"drug_id":"pf-07220060-pf-07104091-combination-dose-escalation","indication_name":"Biomarker-eligible patients with unresectable or metastatic adrenocortical adenoma","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"PF-07220060 + PF-07104091 combination dose escalation","generic_name":"pf-07220060-pf-07104091-combination-dose-escalation","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"pf-07220060-pf-07104091-combination-dose-escalation","indication_name":"Biomarker-eligible patients with unresectable or metastatic adrenocortical adenoma","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"PF-07220060 + PF-07104091 combination dose escalation","generic_name":"pf-07220060-pf-07104091-combination-dose-escalation","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"pf-07220060-pf-07104091-combination-dose-escalation","indication_name":"Biomarker-eligible patients with unresectable or metastatic adrenocortical adenoma","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"PF-07220060 + PF-07104091 combination dose escalation","generic_name":"pf-07220060-pf-07104091-combination-dose-escalation","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"pf-07220060-pf-07104091-combination-dose-escalation","indication_name":"Biomarker-eligible patients with unresectable or metastatic adrenocortical adenoma","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"PF-07220060 + PF-07104091 combination dose escalation","generic_name":"pf-07220060-pf-07104091-combination-dose-escalation","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"pf-07220060-pf-07104091-combination-dose-escalation","indication_name":"Biomarker-eligible patients with unresectable or metastatic adrenocortical adenoma","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"PF-07220060 + PF-07104091 combination dose escalation","generic_name":"pf-07220060-pf-07104091-combination-dose-escalation","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"pf-07220060-pf-07104091-combination-dose-escalation","indication_name":"Biomarker-eligible patients with unresectable or metastatic adrenocortical adenoma","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"PF-07220060 + PF-07104091 combination dose escalation","generic_name":"pf-07220060-pf-07104091-combination-dose-escalation","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"pf-07220060-pf-07104091-combination-dose-escalation","indication_name":"Biomarker-eligible patients with unresectable or metastatic adrenocortical adenoma","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"PF-07220060 + PF-07104091 combination dose escalation","generic_name":"pf-07220060-pf-07104091-combination-dose-escalation","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"pf-07220060-pf-07104091-combination-dose-escalation","indication_name":"Biomarker-eligible patients with unresectable or metastatic adrenocortical adenoma","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"PF-07220060 + PF-07104091 combination dose escalation","generic_name":"pf-07220060-pf-07104091-combination-dose-escalation","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"pf-07220060-pf-07104091-combination-dose-escalation","indication_name":"Biomarker-eligible patients with unresectable or metastatic adrenocortical adenoma","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"PF-07220060 + PF-07104091 combination dose escalation","generic_name":"pf-07220060-pf-07104091-combination-dose-escalation","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"pf-07220060-pf-07104091-combination-dose-escalation","indication_name":"Biomarker-eligible patients with unresectable or metastatic adrenocortical adenoma","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"PF-07220060 + PF-07104091 combination dose escalation","generic_name":"pf-07220060-pf-07104091-combination-dose-escalation","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"pf-07220060-pf-07104091-combination-dose-escalation","indication_name":"Biomarker-eligible patients with unresectable or metastatic adrenocortical adenoma","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"PF-07220060 + PF-07104091 combination dose escalation","generic_name":"pf-07220060-pf-07104091-combination-dose-escalation","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"pf-07220060-pf-07104091-combination-dose-escalation","indication_name":"Biomarker-eligible patients with unresectable or metastatic adrenocortical adenoma","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"PF-07220060 + PF-07104091 combination dose escalation","generic_name":"pf-07220060-pf-07104091-combination-dose-escalation","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"pf-07220060-pf-07104091-combination-dose-escalation","indication_name":"Biomarker-eligible patients with unresectable or metastatic adrenocortical adenoma","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"PF-07220060 + PF-07104091 combination dose escalation","generic_name":"pf-07220060-pf-07104091-combination-dose-escalation","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"pf-07220060-pf-07104091-combination-dose-escalation","indication_name":"Biomarker-eligible patients with unresectable or metastatic adrenocortical adenoma","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"PF-07220060 + PF-07104091 combination dose escalation","generic_name":"pf-07220060-pf-07104091-combination-dose-escalation","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"pf-07220060-pf-07104091-combination-dose-escalation","indication_name":"Biomarker-eligible patients with unresectable or metastatic adrenocortical adenoma","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"PF-07220060 + PF-07104091 combination dose escalation","generic_name":"pf-07220060-pf-07104091-combination-dose-escalation","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"pf-07220060-pf-07104091-combination-dose-escalation","indication_name":"Biomarker-eligible patients with unresectable or metastatic adrenocortical adenoma","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"PF-07220060 + PF-07104091 combination dose escalation","generic_name":"pf-07220060-pf-07104091-combination-dose-escalation","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"pf-07220060-pf-07104091-combination-dose-escalation","indication_name":"Biomarker-eligible patients with unresectable or metastatic adrenocortical adenoma","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"PF-07220060 + PF-07104091 combination dose escalation","generic_name":"pf-07220060-pf-07104091-combination-dose-escalation","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Not specified","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"aldactone","indication_name":"Long-term maintenance therapy for discrete aldosterone-producing adrenal adenomas in non-surgical candidates","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aldactone","generic_name":"Spironolactone","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Aldosterone receptors at aldosterone-dependent sodium-potassium exchange site in distal convoluted renal tubule","drug_class":"Potassium-sparing diuretic, aldosterone antagonist","quality_score":66,"revenue":null,"mechanism":"Aldosterone antagonist causing increased sodium and water excretion while retaining potassium."},{"drug_id":"pantoprazole","indication_name":"Multiple endocrine adenomas","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Protonix","generic_name":"pantoprazole","company_name":"Generic (originally Byk Gulden/Altana/Nycomed)","drug_phase":"marketed","molecular_target":"ATP-binding cassette sub-family G member 2, Fatty acid synthase, Multidrug and toxin extrusion protein 1","drug_class":"Proton pump inhibitor (PPI)","quality_score":58,"revenue":null,"mechanism":"Irreversibly inhibits the gastric proton pump (H+/K+ ATPase), suppressing stomach acid secretion."},{"drug_id":"protonix-iv","indication_name":"Multiple endocrine adenomas","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Pantoprazole Sodium","generic_name":"Pantoprazole Sodium","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"(H+, K+)-ATPase enzyme","drug_class":"Proton pump inhibitor (PPI)","quality_score":69,"revenue":null,"mechanism":"Pantoprazole suppresses gastric acid by covalently binding the (H+, K+)-ATPase enzyme at parietal cells."},{"drug_id":"aciphex","indication_name":"Multiple endocrine adenomas","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Aciphex","company_name":"University of Utah","drug_phase":"marketed","molecular_target":"Sterile alpha and TIR motif-containing protein 1, ATP-binding cassette sub-family G member 2, Adenosine receptor A3","drug_class":"","quality_score":30,"revenue":null,"mechanism":null},{"drug_id":"cimetidine","indication_name":"Multiple endocrine adenomas","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tagamet","generic_name":"CIMETIDINE","company_name":"","drug_phase":"marketed","molecular_target":"Histamine H2 receptor","drug_class":"Histamine-2 Receptor Antagonist [EPC]","quality_score":65,"revenue":null,"mechanism":""},{"drug_id":"rabeprazole","indication_name":"Multiple endocrine adenomas","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aciphex","generic_name":"rabeprazole","company_name":"Waylis","drug_phase":"marketed","molecular_target":"Potassium-transporting ATPase","drug_class":"Proton Pump Inhibitor","quality_score":80,"revenue":null,"mechanism":"Aciphex works by irreversibly inhibiting the potassium-transporting ATPase enzyme in the stomach lining, reducing acid production."},{"drug_id":"tolbutamide","indication_name":"Diagnostic Test for Pancreatic Islet Cell Adenoma","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aglicid","generic_name":"TOLBUTAMIDE","company_name":"","drug_phase":"marketed","molecular_target":"Sulfonylurea receptor 1, Kir6.2","drug_class":"Sulfonylurea","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"rabeprazol","indication_name":"Multiple endocrine adenomas","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Rabeprazol","company_name":"Janssen-Cilag, S.A.","drug_phase":"discontinued","molecular_target":"Sterile alpha and TIR motif-containing protein 1, ATP-binding cassette sub-family G member 2, Adenosine receptor A3","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"pantoprazol","indication_name":"Multiple endocrine adenomas","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pantoprazol","company_name":"Northern Orthopaedic Division, Denmark","drug_phase":"marketed","molecular_target":"ATP-binding cassette sub-family G member 2, Fatty acid synthase, Multidrug and toxin extrusion protein 1","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":26,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06136026","title":"Integrated Chinese and Western Medicine Specialized Disease Cohort for Colorectal Cancer","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":50000,"lead_sponsor_name":"Jiangsu Famous Medical Technology Co., Ltd.","has_results":false},{"nct_id":"NCT04221854","title":"Stool-based SDC2 DNA Methylation Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer","phase":"NA","overall_status":"UNKNOWN","enrollment_count":50000,"lead_sponsor_name":"Sixth Affiliated Hospital, Sun Yat-sen University","has_results":false},{"nct_id":"NCT04369053","title":"Prevention of Colorectal Cancer Through Multiomics Blood Testing","phase":"","overall_status":"COMPLETED","enrollment_count":48995,"lead_sponsor_name":"Freenome Holdings Inc.","has_results":true},{"nct_id":"NCT05183438","title":"Construction of a Prediction Model for Metachronous Colorectal Adenoma","phase":"","overall_status":"UNKNOWN","enrollment_count":30000,"lead_sponsor_name":"The First Affiliated Hospital with Nanjing Medical University","has_results":false},{"nct_id":"NCT06322225","title":"Establishment of Big Data Platform and Biobank for Colorectal Tubular Adenoma Lesions","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":30000,"lead_sponsor_name":"Sixth Affiliated Hospital, Sun Yat-sen University","has_results":false},{"nct_id":"NCT05636085","title":"Clinical Performance of the Mainz Biomed Colorectal Cancer Screening Test for Colorectal Cancer and Advanced Adenoma","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":15000,"lead_sponsor_name":"Mainz Biomed","has_results":false},{"nct_id":"NCT04185779","title":"COLO-COHORT (Colorectal Cancer Cohort) Study","phase":"","overall_status":"RECRUITING","enrollment_count":15000,"lead_sponsor_name":"South Tyneside and Sunderland NHS Foundation Trust","has_results":false},{"nct_id":"NCT04397120","title":"The Factors Affecting ADR of Screening Colonoscopy","phase":"","overall_status":"COMPLETED","enrollment_count":13495,"lead_sponsor_name":"The First Affiliated Hospital of Zhejiang Chinese Medical University","has_results":false},{"nct_id":"NCT04786704","title":"A Stool DNA Test for Detection of Advanced Colorectal Neoplasia in Asymptomatic Chinese Community Population","phase":"","overall_status":"COMPLETED","enrollment_count":12106,"lead_sponsor_name":"Changhai Hospital","has_results":false},{"nct_id":"NCT04693546","title":"Protocol to Validate the Performance of the LifeKit® Prevent Colorectal Neoplasia Test for CRC Screening","phase":"","overall_status":"SUSPENDED","enrollment_count":12000,"lead_sponsor_name":"Metabiomics Corp","has_results":false},{"nct_id":"NCT00461188","title":"Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Barts & The London NHS Trust","has_results":false},{"nct_id":"NCT05612347","title":"Colonoscopy vs Stool Testing for Older Adults With Colon Polyps","phase":"NA","overall_status":"RECRUITING","enrollment_count":8946,"lead_sponsor_name":"Dartmouth-Hitchcock Medical Center","has_results":false},{"nct_id":"NCT00898365","title":"Study of Kidney Tumors in Younger Patients","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":8000,"lead_sponsor_name":"Children's Oncology Group","has_results":false},{"nct_id":"NCT06406062","title":"Artificial Intelligence-assisted System in Colonoscopy","phase":"","overall_status":"RECRUITING","enrollment_count":7500,"lead_sponsor_name":"Renmin Hospital of Wuhan University","has_results":false},{"nct_id":"NCT04490551","title":"Combining Risk Factors and Faecal Immunochemical Testing in Colorectal Cancer Screening: a Randomized Controlled Trial","phase":"NA","overall_status":"COMPLETED","enrollment_count":6753,"lead_sponsor_name":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","has_results":false},{"nct_id":"NCT06649123","title":"Triple Assay of Rectal Mucus in the Diagnosis of Colorectal Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":6600,"lead_sponsor_name":"Origin Sciences","has_results":false},{"nct_id":"NCT03361904","title":"Colonoscopic Adenoma and Advanced Neoplasia Detection Rates According to Age","phase":"","overall_status":"COMPLETED","enrollment_count":6027,"lead_sponsor_name":"Société Française d'Endoscopie Digestive","has_results":false},{"nct_id":"NCT05422820","title":"The Argentina Brief Colonoscopy Difficulty Score (ABCD)","phase":"","overall_status":"COMPLETED","enrollment_count":5000,"lead_sponsor_name":"Institute of Gastroenterology and Advance Endoscopy","has_results":false},{"nct_id":"NCT05463796","title":"InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Dana-Farber Cancer Institute","has_results":false},{"nct_id":"NCT04951557","title":"Setting Benchmarks for Transsphenoidal Resection of Pituitary Adenomas","phase":"","overall_status":"UNKNOWN","enrollment_count":5000,"lead_sponsor_name":"Universitätsklinikum Hamburg-Eppendorf","has_results":false},{"nct_id":"NCT05200611","title":"Fecal Immunochemical Test for Advanced Adenoma Detection in Colorectal Cancer Screening","phase":"","overall_status":"UNKNOWN","enrollment_count":5000,"lead_sponsor_name":"Shandong University","has_results":false},{"nct_id":"NCT04287335","title":"Multitarget Stool FIT-DNA Study for Colorectal Cancer Early Screening in China","phase":"","overall_status":"COMPLETED","enrollment_count":4758,"lead_sponsor_name":"Zhejiang University","has_results":false},{"nct_id":"NCT04472741","title":"Comparison of Newer Colonoscopy Devices With Standard Forward Viewing (SFV) Colonoscopes in Daily Practice","phase":"NA","overall_status":"COMPLETED","enrollment_count":4114,"lead_sponsor_name":"Gastroenterologie Baden-Wettingen","has_results":false},{"nct_id":"NCT07073430","title":"Application Evaluation Research on the Artificial Intelligence-assisted Support System for the Diagnosis of Colorectal Tubular Adenoma Lesions","phase":"","overall_status":"RECRUITING","enrollment_count":4000,"lead_sponsor_name":"Renmin Hospital of Wuhan University","has_results":false},{"nct_id":"NCT05870332","title":"Nationwide Study of Artificial Intelligence in Adenoma Detection for Colonoscopy","phase":"","overall_status":"UNKNOWN","enrollment_count":4000,"lead_sponsor_name":"King's College Hospital NHS Trust","has_results":false},{"nct_id":"NCT04512729","title":"Detection Of Colonic Polyps In India: Diagnostic Colonoscopy","phase":"","overall_status":"UNKNOWN","enrollment_count":4000,"lead_sponsor_name":"Asian Institute of Gastroenterology, India","has_results":false},{"nct_id":"NCT06220617","title":"Multi-omics Study for Early Detection of Colorectal Cancer (MOED-CRC)","phase":"","overall_status":"RECRUITING","enrollment_count":3600,"lead_sponsor_name":"Zhejiang University","has_results":false},{"nct_id":"NCT05402696","title":"St. Paul's Advanced Resection Center Cohort for Colorectal Neoplasia (SPARC-C)","phase":"","overall_status":"RECRUITING","enrollment_count":3500,"lead_sponsor_name":"University of British Columbia","has_results":false},{"nct_id":"NCT06738511","title":"Validation of a Molecular Signature for Early Detection of Colorectal Cancer","phase":"NA","overall_status":"COMPLETED","enrollment_count":3421,"lead_sponsor_name":"ADVANCED MARKER DISCOVERY S.L.","has_results":false},{"nct_id":"NCT04673136","title":"Usefulness of GI-GENIUS in FIT-based Colorectal Cancer Screening Program.","phase":"NA","overall_status":"COMPLETED","enrollment_count":3400,"lead_sponsor_name":"Asociación Española de Gastroenterología","has_results":false},{"nct_id":"NCT03688906","title":"AI-EMERGE: Development and Validation of a Multi-analyte, Blood-based Colorectal Cancer Screening Test","phase":"","overall_status":"COMPLETED","enrollment_count":3275,"lead_sponsor_name":"Freenome Holdings Inc.","has_results":false},{"nct_id":"NCT03072472","title":"BowelScope: Accuracy of Detection Using ENdocuff Optimisation of Mucosal Abnormalities","phase":"NA","overall_status":"COMPLETED","enrollment_count":3221,"lead_sponsor_name":"South Tyneside and Sunderland NHS Foundation Trust","has_results":false},{"nct_id":"NCT05089071","title":"Effect of Two Colonoscopy AI Systems for Colon Polyp Detection","phase":"NA","overall_status":"COMPLETED","enrollment_count":3046,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT03228095","title":"Volatiles in Breath and Headspace Analysis - Diagnostic Markers","phase":"","overall_status":"UNKNOWN","enrollment_count":3000,"lead_sponsor_name":"University of Latvia","has_results":false},{"nct_id":"NCT05254197","title":"SeOuL cOhort of Brain Tumor MONitoring Study (SOLOMON)","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT05152082","title":"Establishment and Validation of a Predictive Model for the Risk of Colorectal Advanced Adenomas","phase":"","overall_status":"UNKNOWN","enrollment_count":3000,"lead_sponsor_name":"The First Affiliated Hospital with Nanjing Medical University","has_results":false},{"nct_id":"NCT06515977","title":"Texture and Colour Enhancement Imaging in Improving Detection and Miss Rate of Premalignant Lesions","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":2964,"lead_sponsor_name":"Changhai Hospital","has_results":false},{"nct_id":"NCT07302139","title":"Risk of Metachronous Advanced Colorectal Neoplastic Among Individuals With Varying Numbers of Non-Advanced Adenomas Detected During Screening Colonoscopy","phase":"","overall_status":"COMPLETED","enrollment_count":2955,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT04767971","title":"Clinical Value of G-EYE Colonoscopy in Daily Practice for Adenoma Detection and Time for Polyp Removal","phase":"","overall_status":"COMPLETED","enrollment_count":2795,"lead_sponsor_name":"Dr. Horst Schmidt Klinik GmbH","has_results":false},{"nct_id":"NCT05125939","title":"Can Overall Adenoma Detection Rate Replace Screening Adenoma Detection Rate ? Multicenter Study","phase":"","overall_status":"RECRUITING","enrollment_count":2700,"lead_sponsor_name":"Evergreen General Hospital, Taiwan","has_results":false},{"nct_id":"NCT00282386","title":"A Study to Evaluate the Effect of MK0966 (Rofecoxib) on the Recurrence of Colorectal Adenomas (0966-122)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":2586,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT05653960","title":"Clinical Outcomes After EMR or ESD of Colorectal Neoplasms - A Multicenter Registry","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":2500,"lead_sponsor_name":"Chinese University of Hong Kong","has_results":false},{"nct_id":"NCT05405673","title":"Diagnostic Accuracy of a Panel of Bacterial Gene Markers (M3) for Colorectal Advanced Neoplasia","phase":"","overall_status":"RECRUITING","enrollment_count":2500,"lead_sponsor_name":"Chinese University of Hong Kong","has_results":false},{"nct_id":"NCT05255588","title":"A Stool DNA-based SDC2 Methylation Test for the Early Detection of Colorectal Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":2358,"lead_sponsor_name":"Genomictree, Inc.","has_results":false},{"nct_id":"NCT03243669","title":"High Definition Endoscopy and Virtual Chromoendoscopy Versus Standard Resolution Endoscopy in Detection of Colon Polyps","phase":"NA","overall_status":"COMPLETED","enrollment_count":2146,"lead_sponsor_name":"Universitaire Ziekenhuizen KU Leuven","has_results":false},{"nct_id":"NCT04440865","title":"Impact of Artificial Intelligence Genius® System-assisted Colonoscopy vs. Standard Colonoscopy (COLO-GENIUS)","phase":"NA","overall_status":"COMPLETED","enrollment_count":2100,"lead_sponsor_name":"Clinique Paris-Bercy","has_results":false},{"nct_id":"NCT00339625","title":"Polyp Prevention Trial","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":2079,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT03344055","title":"Endocuff-assisted Colonoscopy vs Standard Colonoscopy on Adenoma Detection Rate","phase":"NA","overall_status":"COMPLETED","enrollment_count":2059,"lead_sponsor_name":"Société Française d'Endoscopie Digestive","has_results":false},{"nct_id":"NCT04723758","title":"COLO-DETECT: Can an Artificial Intelligence Device Increase Detection of Polyps During Colonoscopy?","phase":"NA","overall_status":"COMPLETED","enrollment_count":2032,"lead_sponsor_name":"South Tyneside and Sunderland NHS Foundation Trust","has_results":false},{"nct_id":"NCT04049357","title":"Care for Colon 2015","phase":"NA","overall_status":"COMPLETED","enrollment_count":2031,"lead_sponsor_name":"Odense University Hospital","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}